Momenta Pharmaceuticals to Webcast Presentation at the UBS 2015 Global Healthcare Conference
Get Alerts MNTA Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass., May 12, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that its presentation at the UBS 2015 Global Healthcare Conference will be webcast on Tuesday, May 19, 2015 at 4:30 p.m. ET.
The audio webcast of the presentation will be available live on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.
About Momenta Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications.
To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.
CONTACT: Sarah Carmody Momenta Pharmaceuticals 1-617-395-5189 [email protected]Source: Momenta Pharmaceuticals
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Migrity Business Talent Academy Announces Innovative AI Entrepreneurship
- Rocket Lab Successfully Deploys Satellites ~500km Apart to Separate Orbits For KAIST and NASA
- GRUPO ELEKTRA ANNOUNCES REVENUE OF Ps.44,562 MILLION AND EBITDA OF Ps.6,363 MILLION IN THE FIRST QUARTER OF 2024
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!